Joint scientific opinion assesses the likelihood of swine-origin influenza A(H3N2) in the EU as low
The joint scientific opinion by three EU agencies assesses and advises on the possible risks posed by influenza A(H3N2)v virus for animal health and the potential implications for animal and human health.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season; A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus, B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage). The WHO recommendations are made with a knowledge of the currently circulating viruses globally. WHO recommended two changes, compared to the current trivalent and quadrivalent vaccines for the 2017–2018 season in the northern hemisphere influenza season.
This paper highlights the difficulties that developing countries face in preparing for an influenza pandemic suggesting that approaches applicable in rich countries will not suffice to protect the population since supplies of vaccines and antiviral agents cannot be used.
Investigation of the temporal association of Guillain-Barre´ Syndrome with influenza vaccine and influenza-like illness
This paper details the use of the self-controlled case series method developed by this group and others to investigate the relation of Guillain-Barre syndrome (GBS) with influenza vaccination and influenza-like illness using data from the General Practice Research Database from 1990 to 2005, in the UK.
A Series of publications on oseltamivir resistance in seasonal influenza – A(H1N1-H247Y)
This week has seen a particular flock of article eto the influenza antiviral resistance topic which was first observed in Europe in January 2008 (1,2) but have since been recognised as a global phenomenon.
Trials and Tribulations
Two randomised controlled trials of personal public health measures in Australia and Hong Kong investigating effectiveness of the use of face masks and hand washing in the prevention of secondary cases of influenza-like illness (ILI) or actual influenza in households following diagnosis of a confirmed case of seasonal flu in one family member.
Use of antigens derived from plants to produce recombinant influenza vaccines opens new ways of pandemic influenza vaccine development
Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.
Impact of universal influenza vaccination policy in Ontario and its implications for vaccination policies in Europe
In 2000 the large Canadian province of Ontario started making seasonal influenza vaccination recommended and available at no cost to all in the province over 6 months of age.